Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 4, 2005, Pages 1054-1061

  Suh, W Warren ^a,c   Hillner, Bruce E ^b   Pierce, Lori J ^a   Hayman, James A ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Breast cancer; Cost effectiveness; Ductal carcinoma in situ; Radiation

Indexed keywords

COST EFFECTIVENESS; MARKOV PROCESSES; MATHEMATICAL MODELS; PATIENT TREATMENT; PROBABILITY; PROJECT MANAGEMENT; SENSITIVITY ANALYSIS; SURGERY;

BREAST-CONSERVING SURGERY (BCS); DUCTAL CARCINOMA IN SITU (DCIS); INCREMENTAL COST-EFFECTIVE RATIO (ICER); QUALITY-ADJUSTED LIFE-YEARS (QALY);

RADIOTHERAPY;

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CARCINOMA IN SITU; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEE; FEMALE; HEALTH CARE COST; HUMAN; INTRADUCTAL CARCINOMA; LIFESPAN; LYMPH NODE METASTASIS; MEDICARE; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; RECURRENT CANCER; SALVAGE THERAPY; SENSITIVITY ANALYSIS; THEORY; TIME; TRAFFIC AND TRANSPORT;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; COST-BENEFIT ANALYSIS; DECISION TREES; FEMALE; HUMANS; MARKOV CHAINS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; QUALITY-ADJUSTED LIFE YEARS; RADIOTHERAPY; SENSITIVITY AND SPECIFICITY;

EID: 14844293124     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.07.713     Document Type: Article

References (21)

1. V.L. Ernster, J. Barclay, K. Kerlikowske Incidence of and treatment for ductal carcinoma in situ of the breast JAMA 275 1996 913 918
2. V.L. Ernster, R. Ballard-Barbash, W.E. Barlow Detection of ductal carcinoma in situ in women undergoing screening mammography J Natl Cancer Inst 94 2002 1546 1554
3. B. Fisher, S. Land, E. Mamounas Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experience Semin Oncol 28 2001 400 418
4. National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program. SEER incidence crude rates, 11 registries, 1973-1997. http://seer.cancer.gov/Publications/CSR1973_1997/breast.pdf.
5. B. Fisher, J. Dignam, N. Wolmark Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17 J Clin Oncol 16 1998 441 452
6. N. Bijker, J.L. Peterse, L. Duchateau Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma in situ: Analysis of the European Organization for Research and Treatment of Cancer (EORTC) trial 10853 Lancet 19 2001 2263 2271
7. J. Houghton, W.D. George, J. Cuzick Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: Randomised controlled trial Lancet 362 2003 95 102
8. National Center for Health Statistics, CDC United States abridged life tables, 1999 Natl Vital Stat Rep 50 2002 11 12
9. W.B. van den Hout, Y.M. van der Linden, E. Steenland Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: Cost-utility analysis based on a randomized trial J Natl Cancer Inst 95 2003 222 229
10. U.S. Bureau of the Census. Current population reports: Money income in the United States 2001 (with separate data on valuation of noncash benefits). Washington, DC: United States Government Printing Office; 2002. p. 2.
11. J.L. Warren, M.L. Brown, M.P. Fay Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings J Clin Oncol 20 2002 307 316
12. G.F. Riley, A.L. Potosky, J.D. Lubitz Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis Med Care 33 1995 828 841
13. H. Kattlove, A. Liberati, E. Keeler Benefits and costs of screening and treatment for early breast cancer: Development of a basic benefit package JAMA 273 1995 142 148
14. J. Lipscomb, M.C. Weinstein, G.W. Torrance Time preference M.R. Gold J.E. Siegel L.B. Russell M.C. Weinstein Cost-effectiveness in health and medicine 1996 Oxford University Press New York 233
15. J.A. Hayman, B.E. Hillner, J.R. Harris Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer J Clin Oncol 16 1998 1022 1029
16. J.H. Lee, H.A. Glick, J.A. Hayman Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast cancer patients J Clin Oncol 20 2002 2713 2725
17. W.E. Barlow, S.H. Taplin, C.K. Yoshida Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer J Natl Cancer Inst 93 2001 447 455
18. Bradley CJ, Given C, Baser O, et al. Influence of surgical and treatment choices on the cost of breast cancer care. Eur J Health Econ 2003;4:96-101.
19. F.A. Vicini, A. Recht Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: A critical review of the literature J Clin Oncol 20 2000 296 306
20. D.B. Petitti Meta-analysis, decision analysis, and cost-effectiveness analysis 2000 Oxford University Press 2nd ed. New York p. 94-118.
21. J.A. Hayman, B.E. Hillner, J.A. Harris Cost-effectiveness of adding an electron-beam boost to tangential radiation therapy in patients with negative margins after conservative surgery for early-stage breast cancer J Clin Oncol 18 2000 287 295